DEF 14A: Tempest Therapeutics Seeks Stockholder Approval for Reverse Stock Split to Boost Marketability

Tempest Therapeutics is asking stockholders to approve a reverse stock split, ranging from 1-for-2 to 1-for-15, to potentially improve the marketability and liquidity of its common stock.

Summary

• Tempest Therapeutics is holding a special meeting on December 3, 2024, to seek stockholder approval for a reverse stock split.
• The proposed reverse stock split would allow the Board of Directors to consolidate shares at a ratio between 1-for-2 and 1-for-15.
• The Board believes this could improve the marketability and liquidity of the company's stock.
• The Board will determine the specific ratio and timing, if approved, before December 3, 2025.
• If a reverse stock split is implemented, stockholders may receive cash in lieu of fractional shares.
• The company's common stock is currently registered under Section 12(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and we are subject to the periodic reporting and other requirements of the Exchange Act.
• The implementation of any proposed Reverse Stock Split will not affect the registration of our common stock under the Exchange Act.
• Our common stock would continue to be listed on the Nasdaq Capital Market under the symbol TPST immediately following the Reverse Stock Split, although it is likely that Nasdaq would add the letter D to the end of the trading symbol for a period of twenty trading days after the effective date of the Reverse Stock Split to indicate that the Reverse Stock Split had occurred.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting both the potential benefits and risks of the proposed reverse stock split. The sentiment is moderately positive as the company is trying to improve its market position, but there are inherent risks associated with the action.

Positives

• The reverse stock split could improve the marketability and liquidity of the company's common stock.
• A higher stock price may attract institutional investors and brokerage houses.
• It could increase analyst and broker interest in the company.
• The Board of Directors has the flexibility to choose the most appropriate ratio within the approved range.
• The company will provide cash payments in lieu of fractional shares, simplifying the process for stockholders.

Negatives

• There is no guarantee that the reverse stock split will increase the stock price for a sustained period.
• The reverse stock split may decrease the liquidity of the common stock.
• Transaction costs for odd lots (fewer than 100 shares) may increase.
• The effective increase in authorized shares could have anti-takeover implications.
• If the trading price of the common stock declines, the percentage decline as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of the Reverse Stock Split.

Risks

• The stock price may not increase proportionally to the reduction in outstanding shares.
• The reverse stock split may not attract the desired institutional investors.
• The market price of the common stock may decrease due to factors unrelated to the reverse stock split.
• The liquidity of the common stock may be negatively impacted.
• The effective increase in the authorized number of shares of our common stock as a result of the Reverse Stock Split could have anti-takeover implications.

Future Outlook

The Board of Directors will determine whether to implement the reverse stock split and the specific ratio based on market conditions and other factors, with a deadline of one year from the Special Meeting.

Management Comments

• Our Board of Directors believes that the increased market price of our common stock expected as a result of implementing a Reverse Stock Split could improve the marketability and liquidity of our common stock and encourage interest and trading in our common stock.

Industry Context

Reverse stock splits are often used by companies to regain compliance with stock exchange listing requirements or to improve investor perception by increasing the stock price. It is a common strategy for companies with low stock prices.

Comparison to Industry Standards

• Many companies in the biotechnology sector have used reverse stock splits to maintain Nasdaq listing compliance, including companies such as BioDelivery Sciences International and Aeterna Zentaris.
• The success of a reverse stock split varies, with some companies seeing a sustained increase in stock price while others experience a decline after the initial effect.

Stakeholder Impact

• Shareholders may see a change in the number of shares they own, but their percentage ownership will remain the same (except for fractional shares).
• Employees with stock options or restricted stock units will see adjustments to the exercise price and number of shares.
• The company hopes to attract new investors and improve trading liquidity, benefiting all stakeholders.

Next Steps

• Stockholder vote on the reverse stock split proposal at the Special Meeting on December 3, 2024.
• Board of Directors decision on whether to implement the reverse stock split and the specific ratio, if approved.
• Filing of Certificate of Amendment with the Secretary of State of Delaware, if the Board decides to proceed.
• Implementation of the reverse stock split by December 3, 2025, if approved.

Key Dates

Keywords

reverse stock split, proxy statement, stockholders, common stock, marketability, liquidity, board of directors